Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intraperitoneal therapy with interferon-alpha in CAPD patients with relapsing bacterial peritonitis.

S Carozzi1, M G Nasini, C Schelotto

  • 1Nephrology and Dialysis Unit, St. Paul's Hospital, Savona, Italy.

ASAIO Transactions
|July 1, 1989
PubMed
Summary

Interferon-alpha (IFN-alpha) therapy improved peritoneal macrophage function in patients with relapsing bacterial peritonitis. This treatment prevented further infection episodes in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pressure tuning of light-induced superconductivity in K<sub>3</sub>C<sub>60</sub>.

Nature physics·2018
Same author

Possible light-induced superconductivity in K3C60 at high temperature.

Nature·2016
Same author

Prospects for enhancement of Ring Laser Gyroscopes using gaseous media.

Optics express·2012
Same author

Ultra-low power, Zeno effect based optical modulation in a degenerate V-system with a tapered nano fiber in atomic vapor.

Optics express·2011
Same author

Superluminal ring laser for hypersensitive sensing.

Optics express·2010
Same author

Simultaneous slow and fast light effects using probe gain and pump depletion via Raman gain in atomic vapor.

Optics express·2009

Area of Science:

  • Immunology
  • Nephrology
  • Infectious Diseases

Background:

  • Continuous ambulatory peritoneal dialysis (CAPD) patients with relapsing bacterial peritonitis may not respond to immunoglobulin G (IgG) therapy.
  • These patients exhibit peritoneal macrophages deficient in IgG Fc receptors (FcR), impairing bacterial killing capacity.

Purpose of the Study:

  • To investigate the in vivo efficacy of intraperitoneal (IP) interferon-alpha (IFN-alpha) in treating CAPD patients with relapsing bacterial peritonitis.
  • To assess the impact of IFN-alpha on peritoneal macrophage (PM0) function, bacterial clearance, and peritonitis recurrence.

Main Methods:

  • IP administration of IFN-alpha (1,000 IU daily for 12 months) in CAPD patients with relapsing bacterial peritonitis.
  • Evaluation of PM0 superoxide generation, bacterial killing, IgG FcR expression, intracellular bacterial counts, and peritonitis relapse rates.

Related Experiment Videos

Main Results:

  • IFN-alpha treatment significantly enhanced PM0 superoxide generation and bacterial killing capacity within 10 days.
  • The therapy led to increased PM0 IgG FcR expression and reduced intracellular bacteria.
  • No peritonitis relapses were observed in patients during the 12-month treatment period.

Conclusions:

  • IP IFN-alpha effectively restores peritoneal macrophage function in CAPD patients with relapsing bacterial peritonitis.
  • IFN-alpha demonstrates potential as a therapeutic agent for preventing recurrent infections in this patient population.